nodes	percent_of_prediction	percent_of_DWPC	metapath
Eplerenone—NR3C2—Betamethasone—psoriatic arthritis	0.144	0.322	CbGbCtD
Eplerenone—NR3C2—Prednisolone—psoriatic arthritis	0.142	0.318	CbGbCtD
Eplerenone—NR3C2—Dexamethasone—psoriatic arthritis	0.0838	0.187	CbGbCtD
Eplerenone—Medroxyprogesterone Acetate—Methylprednisolone—psoriatic arthritis	0.0264	0.0513	CrCrCtD
Eplerenone—Hydrocortamate—Methylprednisolone—psoriatic arthritis	0.0238	0.0463	CrCrCtD
Eplerenone—Cortisone acetate—Methylprednisolone—psoriatic arthritis	0.0231	0.0449	CrCrCtD
Eplerenone—Hydrocortamate—Prednisone—psoriatic arthritis	0.0217	0.0423	CrCrCtD
Eplerenone—Hydrocortamate—Prednisolone—psoriatic arthritis	0.0212	0.0413	CrCrCtD
Eplerenone—Cortisone acetate—Prednisone—psoriatic arthritis	0.021	0.041	CrCrCtD
Eplerenone—Cortisone acetate—Prednisolone—psoriatic arthritis	0.0205	0.04	CrCrCtD
Eplerenone—Fluoxymesterone—Dexamethasone—psoriatic arthritis	0.0202	0.0394	CrCrCtD
Eplerenone—Fluoxymesterone—Betamethasone—psoriatic arthritis	0.0202	0.0394	CrCrCtD
Eplerenone—Fludrocortisone—Methylprednisolone—psoriatic arthritis	0.02	0.039	CrCrCtD
Eplerenone—Fluoxymesterone—Triamcinolone—psoriatic arthritis	0.0198	0.0385	CrCrCtD
Eplerenone—Fludrocortisone—Betamethasone—psoriatic arthritis	0.0197	0.0384	CrCrCtD
Eplerenone—Fludrocortisone—Dexamethasone—psoriatic arthritis	0.0197	0.0384	CrCrCtD
Eplerenone—Fludrocortisone—Triamcinolone—psoriatic arthritis	0.0193	0.0375	CrCrCtD
Eplerenone—Fluoxymesterone—Prednisolone—psoriatic arthritis	0.0183	0.0357	CrCrCtD
Eplerenone—Fludrocortisone—Prednisone—psoriatic arthritis	0.0183	0.0356	CrCrCtD
Eplerenone—Fludrocortisone—Prednisolone—psoriatic arthritis	0.0178	0.0348	CrCrCtD
Eplerenone—Progesterone—Prednisolone—psoriatic arthritis	0.0178	0.0348	CrCrCtD
Eplerenone—Methyltestosterone—Prednisone—psoriatic arthritis	0.0178	0.0347	CrCrCtD
Eplerenone—Methyltestosterone—Prednisolone—psoriatic arthritis	0.0174	0.0339	CrCrCtD
Eplerenone—Hydrocortisone—Methylprednisolone—psoriatic arthritis	0.0163	0.0318	CrCrCtD
Eplerenone—Hydrocortisone—Dexamethasone—psoriatic arthritis	0.0161	0.0313	CrCrCtD
Eplerenone—Hydrocortisone—Betamethasone—psoriatic arthritis	0.0161	0.0313	CrCrCtD
Eplerenone—Hydrocortisone—Triamcinolone—psoriatic arthritis	0.0157	0.0306	CrCrCtD
Eplerenone—Testosterone—Prednisolone—psoriatic arthritis	0.0155	0.0302	CrCrCtD
Eplerenone—Hydrocortisone—Prednisone—psoriatic arthritis	0.0149	0.029	CrCrCtD
Eplerenone—Hydrocortisone—Prednisolone—psoriatic arthritis	0.0146	0.0283	CrCrCtD
Eplerenone—CYP3A7-CYP3A51P—Dexamethasone—psoriatic arthritis	0.0132	0.0295	CbGbCtD
Eplerenone—CYP3A7—Dexamethasone—psoriatic arthritis	0.0132	0.0295	CbGbCtD
Eplerenone—CYP3A4—Methylprednisolone—psoriatic arthritis	0.0102	0.0228	CbGbCtD
Eplerenone—CYP3A5—Dexamethasone—psoriatic arthritis	0.00989	0.0221	CbGbCtD
Eplerenone—CYP3A4—Triamcinolone—psoriatic arthritis	0.00772	0.0173	CbGbCtD
Eplerenone—CYP3A4—Betamethasone—psoriatic arthritis	0.00663	0.0148	CbGbCtD
Eplerenone—CYP3A4—Prednisolone—psoriatic arthritis	0.00654	0.0146	CbGbCtD
Eplerenone—CYP3A4—Prednisone—psoriatic arthritis	0.00618	0.0138	CbGbCtD
Eplerenone—CYP3A4—Dexamethasone—psoriatic arthritis	0.00385	0.00862	CbGbCtD
Eplerenone—Hyperglycaemia—Betamethasone—psoriatic arthritis	0.000148	0.00376	CcSEcCtD
Eplerenone—Alanine aminotransferase increased—Prednisone—psoriatic arthritis	0.000146	0.0037	CcSEcCtD
Eplerenone—Acute coronary syndrome—Dexamethasone—psoriatic arthritis	0.000144	0.00366	CcSEcCtD
Eplerenone—Acute coronary syndrome—Betamethasone—psoriatic arthritis	0.000144	0.00366	CcSEcCtD
Eplerenone—Pharyngitis—Triamcinolone—psoriatic arthritis	0.000144	0.00365	CcSEcCtD
Eplerenone—Neuropathy peripheral—Dexamethasone—psoriatic arthritis	0.000144	0.00364	CcSEcCtD
Eplerenone—Myocardial infarction—Betamethasone—psoriatic arthritis	0.000144	0.00364	CcSEcCtD
Eplerenone—Neuropathy peripheral—Betamethasone—psoriatic arthritis	0.000144	0.00364	CcSEcCtD
Eplerenone—Myocardial infarction—Dexamethasone—psoriatic arthritis	0.000144	0.00364	CcSEcCtD
Eplerenone—Connective tissue disorder—Methylprednisolone—psoriatic arthritis	0.000142	0.0036	CcSEcCtD
Eplerenone—Cardiac disorder—Methylprednisolone—psoriatic arthritis	0.000134	0.0034	CcSEcCtD
Eplerenone—Angiopathy—Methylprednisolone—psoriatic arthritis	0.000131	0.00332	CcSEcCtD
Eplerenone—Mediastinal disorder—Methylprednisolone—psoriatic arthritis	0.00013	0.0033	CcSEcCtD
Eplerenone—Hyperglycaemia—Prednisone—psoriatic arthritis	0.000129	0.00327	CcSEcCtD
Eplerenone—Ill-defined disorder—Prednisolone—psoriatic arthritis	0.000127	0.00323	CcSEcCtD
Eplerenone—Depression—Prednisone—psoriatic arthritis	0.000127	0.00322	CcSEcCtD
Eplerenone—Mental disorder—Methylprednisolone—psoriatic arthritis	0.000127	0.00321	CcSEcCtD
Eplerenone—Malnutrition—Methylprednisolone—psoriatic arthritis	0.000126	0.00319	CcSEcCtD
Eplerenone—Acute coronary syndrome—Prednisone—psoriatic arthritis	0.000126	0.00319	CcSEcCtD
Eplerenone—Angioedema—Prednisolone—psoriatic arthritis	0.000125	0.00318	CcSEcCtD
Eplerenone—Neuropathy peripheral—Prednisone—psoriatic arthritis	0.000125	0.00317	CcSEcCtD
Eplerenone—Myocardial infarction—Prednisone—psoriatic arthritis	0.000125	0.00317	CcSEcCtD
Eplerenone—Malaise—Prednisolone—psoriatic arthritis	0.000124	0.00314	CcSEcCtD
Eplerenone—Syncope—Prednisolone—psoriatic arthritis	0.000123	0.00312	CcSEcCtD
Eplerenone—Back pain—Triamcinolone—psoriatic arthritis	0.000122	0.00309	CcSEcCtD
Eplerenone—Loss of consciousness—Prednisolone—psoriatic arthritis	0.000121	0.00306	CcSEcCtD
Eplerenone—Angiopathy—Dexamethasone—psoriatic arthritis	0.000119	0.00302	CcSEcCtD
Eplerenone—Angiopathy—Betamethasone—psoriatic arthritis	0.000119	0.00302	CcSEcCtD
Eplerenone—Eosinophilia—Methotrexate—psoriatic arthritis	0.000118	0.003	CcSEcCtD
Eplerenone—Ill-defined disorder—Triamcinolone—psoriatic arthritis	0.000117	0.00297	CcSEcCtD
Eplerenone—Ill-defined disorder—Methylprednisolone—psoriatic arthritis	0.000117	0.00296	CcSEcCtD
Eplerenone—Discomfort—Prednisolone—psoriatic arthritis	0.000115	0.00292	CcSEcCtD
Eplerenone—Angioedema—Triamcinolone—psoriatic arthritis	0.000115	0.00292	CcSEcCtD
Eplerenone—Angioedema—Methylprednisolone—psoriatic arthritis	0.000115	0.00292	CcSEcCtD
Eplerenone—Malaise—Triamcinolone—psoriatic arthritis	0.000114	0.00288	CcSEcCtD
Eplerenone—Malaise—Methylprednisolone—psoriatic arthritis	0.000113	0.00288	CcSEcCtD
Eplerenone—Syncope—Triamcinolone—psoriatic arthritis	0.000113	0.00287	CcSEcCtD
Eplerenone—Syncope—Methylprednisolone—psoriatic arthritis	0.000113	0.00286	CcSEcCtD
Eplerenone—Connective tissue disorder—Prednisone—psoriatic arthritis	0.000112	0.00285	CcSEcCtD
Eplerenone—Upper respiratory tract infection—Methotrexate—psoriatic arthritis	0.000111	0.00282	CcSEcCtD
Eplerenone—Loss of consciousness—Triamcinolone—psoriatic arthritis	0.000111	0.00281	CcSEcCtD
Eplerenone—Loss of consciousness—Methylprednisolone—psoriatic arthritis	0.000111	0.0028	CcSEcCtD
Eplerenone—Shock—Prednisolone—psoriatic arthritis	0.00011	0.00279	CcSEcCtD
Eplerenone—Cough—Triamcinolone—psoriatic arthritis	0.00011	0.00279	CcSEcCtD
Eplerenone—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.000108	0.00274	CcSEcCtD
Eplerenone—Myalgia—Triamcinolone—psoriatic arthritis	0.000107	0.00272	CcSEcCtD
Eplerenone—Pneumonia—Methotrexate—psoriatic arthritis	0.000107	0.00272	CcSEcCtD
Eplerenone—Myalgia—Methylprednisolone—psoriatic arthritis	0.000107	0.00272	CcSEcCtD
Eplerenone—Arthralgia—Methylprednisolone—psoriatic arthritis	0.000107	0.00272	CcSEcCtD
Eplerenone—Infestation—Methotrexate—psoriatic arthritis	0.000107	0.0027	CcSEcCtD
Eplerenone—Infestation NOS—Methotrexate—psoriatic arthritis	0.000107	0.0027	CcSEcCtD
Eplerenone—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.000106	0.0027	CcSEcCtD
Eplerenone—Depression—Methotrexate—psoriatic arthritis	0.000106	0.00269	CcSEcCtD
Eplerenone—Flushing—Prednisone—psoriatic arthritis	0.000106	0.00269	CcSEcCtD
Eplerenone—Ill-defined disorder—Dexamethasone—psoriatic arthritis	0.000106	0.00269	CcSEcCtD
Eplerenone—Ill-defined disorder—Betamethasone—psoriatic arthritis	0.000106	0.00269	CcSEcCtD
Eplerenone—Discomfort—Triamcinolone—psoriatic arthritis	0.000106	0.00269	CcSEcCtD
Eplerenone—Discomfort—Methylprednisolone—psoriatic arthritis	0.000106	0.00268	CcSEcCtD
Eplerenone—Renal failure—Methotrexate—psoriatic arthritis	0.000105	0.00266	CcSEcCtD
Eplerenone—Angioedema—Dexamethasone—psoriatic arthritis	0.000105	0.00265	CcSEcCtD
Eplerenone—Angioedema—Betamethasone—psoriatic arthritis	0.000105	0.00265	CcSEcCtD
Eplerenone—Angiopathy—Prednisone—psoriatic arthritis	0.000104	0.00263	CcSEcCtD
Eplerenone—Malaise—Betamethasone—psoriatic arthritis	0.000103	0.00262	CcSEcCtD
Eplerenone—Malaise—Dexamethasone—psoriatic arthritis	0.000103	0.00262	CcSEcCtD
Eplerenone—Syncope—Betamethasone—psoriatic arthritis	0.000103	0.0026	CcSEcCtD
Eplerenone—Syncope—Dexamethasone—psoriatic arthritis	0.000103	0.0026	CcSEcCtD
Eplerenone—Infection—Triamcinolone—psoriatic arthritis	0.000102	0.00259	CcSEcCtD
Eplerenone—Infection—Methylprednisolone—psoriatic arthritis	0.000102	0.00259	CcSEcCtD
Eplerenone—Haematuria—Methotrexate—psoriatic arthritis	0.000102	0.00258	CcSEcCtD
Eplerenone—Shock—Triamcinolone—psoriatic arthritis	0.000101	0.00257	CcSEcCtD
Eplerenone—Insomnia—Prednisolone—psoriatic arthritis	0.000101	0.00257	CcSEcCtD
Eplerenone—Shock—Methylprednisolone—psoriatic arthritis	0.000101	0.00256	CcSEcCtD
Eplerenone—Hepatobiliary disease—Methotrexate—psoriatic arthritis	0.000101	0.00256	CcSEcCtD
Eplerenone—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.000101	0.00255	CcSEcCtD
Eplerenone—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.000101	0.00255	CcSEcCtD
Eplerenone—Loss of consciousness—Betamethasone—psoriatic arthritis	0.000101	0.00255	CcSEcCtD
Eplerenone—Mental disorder—Prednisone—psoriatic arthritis	0.0001	0.00254	CcSEcCtD
Eplerenone—Skin disorder—Methylprednisolone—psoriatic arthritis	9.98e-05	0.00253	CcSEcCtD
Eplerenone—Malnutrition—Prednisone—psoriatic arthritis	9.97e-05	0.00253	CcSEcCtD
Eplerenone—Hyperhidrosis—Triamcinolone—psoriatic arthritis	9.95e-05	0.00252	CcSEcCtD
Eplerenone—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	9.93e-05	0.00252	CcSEcCtD
Eplerenone—Myalgia—Dexamethasone—psoriatic arthritis	9.74e-05	0.00247	CcSEcCtD
Eplerenone—Myalgia—Betamethasone—psoriatic arthritis	9.74e-05	0.00247	CcSEcCtD
Eplerenone—Discomfort—Betamethasone—psoriatic arthritis	9.63e-05	0.00244	CcSEcCtD
Eplerenone—Discomfort—Dexamethasone—psoriatic arthritis	9.63e-05	0.00244	CcSEcCtD
Eplerenone—Hypotension—Methylprednisolone—psoriatic arthritis	9.6e-05	0.00243	CcSEcCtD
Eplerenone—Pain—Prednisolone—psoriatic arthritis	9.57e-05	0.00243	CcSEcCtD
Eplerenone—Pharyngitis—Methotrexate—psoriatic arthritis	9.5e-05	0.00241	CcSEcCtD
Eplerenone—Urinary tract disorder—Methotrexate—psoriatic arthritis	9.45e-05	0.0024	CcSEcCtD
Eplerenone—Urethral disorder—Methotrexate—psoriatic arthritis	9.38e-05	0.00238	CcSEcCtD
Eplerenone—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	9.38e-05	0.00238	CcSEcCtD
Eplerenone—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	9.36e-05	0.00237	CcSEcCtD
Eplerenone—Insomnia—Triamcinolone—psoriatic arthritis	9.31e-05	0.00236	CcSEcCtD
Eplerenone—Insomnia—Methylprednisolone—psoriatic arthritis	9.29e-05	0.00235	CcSEcCtD
Eplerenone—Infection—Dexamethasone—psoriatic arthritis	9.28e-05	0.00235	CcSEcCtD
Eplerenone—Infection—Betamethasone—psoriatic arthritis	9.28e-05	0.00235	CcSEcCtD
Eplerenone—Ill-defined disorder—Prednisone—psoriatic arthritis	9.25e-05	0.00234	CcSEcCtD
Eplerenone—Feeling abnormal—Prednisolone—psoriatic arthritis	9.22e-05	0.00234	CcSEcCtD
Eplerenone—Anaemia—Prednisone—psoriatic arthritis	9.21e-05	0.00234	CcSEcCtD
Eplerenone—Shock—Betamethasone—psoriatic arthritis	9.19e-05	0.00233	CcSEcCtD
Eplerenone—Shock—Dexamethasone—psoriatic arthritis	9.19e-05	0.00233	CcSEcCtD
Eplerenone—Dyspnoea—Triamcinolone—psoriatic arthritis	9.18e-05	0.00233	CcSEcCtD
Eplerenone—Nervous system disorder—Dexamethasone—psoriatic arthritis	9.16e-05	0.00232	CcSEcCtD
Eplerenone—Nervous system disorder—Betamethasone—psoriatic arthritis	9.16e-05	0.00232	CcSEcCtD
Eplerenone—Angioedema—Prednisone—psoriatic arthritis	9.11e-05	0.00231	CcSEcCtD
Eplerenone—Dyspepsia—Triamcinolone—psoriatic arthritis	9.06e-05	0.0023	CcSEcCtD
Eplerenone—Dyspepsia—Methylprednisolone—psoriatic arthritis	9.04e-05	0.00229	CcSEcCtD
Eplerenone—Hyperhidrosis—Betamethasone—psoriatic arthritis	9.03e-05	0.00229	CcSEcCtD
Eplerenone—Hyperhidrosis—Dexamethasone—psoriatic arthritis	9.03e-05	0.00229	CcSEcCtD
Eplerenone—Malaise—Prednisone—psoriatic arthritis	8.99e-05	0.00228	CcSEcCtD
Eplerenone—Syncope—Prednisone—psoriatic arthritis	8.94e-05	0.00227	CcSEcCtD
Eplerenone—Tinnitus—Methotrexate—psoriatic arthritis	8.92e-05	0.00226	CcSEcCtD
Eplerenone—Cardiac disorder—Methotrexate—psoriatic arthritis	8.88e-05	0.00225	CcSEcCtD
Eplerenone—Fatigue—Triamcinolone—psoriatic arthritis	8.87e-05	0.00225	CcSEcCtD
Eplerenone—Fatigue—Methylprednisolone—psoriatic arthritis	8.85e-05	0.00224	CcSEcCtD
Eplerenone—Pain—Triamcinolone—psoriatic arthritis	8.8e-05	0.00223	CcSEcCtD
Eplerenone—Loss of consciousness—Prednisone—psoriatic arthritis	8.76e-05	0.00222	CcSEcCtD
Eplerenone—Hypotension—Dexamethasone—psoriatic arthritis	8.73e-05	0.00221	CcSEcCtD
Eplerenone—Hypotension—Betamethasone—psoriatic arthritis	8.73e-05	0.00221	CcSEcCtD
Eplerenone—Angiopathy—Methotrexate—psoriatic arthritis	8.68e-05	0.0022	CcSEcCtD
Eplerenone—Mediastinal disorder—Methotrexate—psoriatic arthritis	8.62e-05	0.00219	CcSEcCtD
Eplerenone—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	8.51e-05	0.00216	CcSEcCtD
Eplerenone—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	8.51e-05	0.00216	CcSEcCtD
Eplerenone—Arthralgia—Prednisone—psoriatic arthritis	8.48e-05	0.00215	CcSEcCtD
Eplerenone—Myalgia—Prednisone—psoriatic arthritis	8.48e-05	0.00215	CcSEcCtD
Eplerenone—Feeling abnormal—Triamcinolone—psoriatic arthritis	8.48e-05	0.00215	CcSEcCtD
Eplerenone—Feeling abnormal—Methylprednisolone—psoriatic arthritis	8.46e-05	0.00215	CcSEcCtD
Eplerenone—Insomnia—Dexamethasone—psoriatic arthritis	8.45e-05	0.00214	CcSEcCtD
Eplerenone—Insomnia—Betamethasone—psoriatic arthritis	8.45e-05	0.00214	CcSEcCtD
Eplerenone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	8.43e-05	0.00214	CcSEcCtD
Eplerenone—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	8.4e-05	0.00213	CcSEcCtD
Eplerenone—Discomfort—Prednisone—psoriatic arthritis	8.38e-05	0.00213	CcSEcCtD
Eplerenone—Mental disorder—Methotrexate—psoriatic arthritis	8.38e-05	0.00213	CcSEcCtD
Eplerenone—Malnutrition—Methotrexate—psoriatic arthritis	8.33e-05	0.00211	CcSEcCtD
Eplerenone—Dyspepsia—Dexamethasone—psoriatic arthritis	8.22e-05	0.00208	CcSEcCtD
Eplerenone—Dyspepsia—Betamethasone—psoriatic arthritis	8.22e-05	0.00208	CcSEcCtD
Eplerenone—Body temperature increased—Triamcinolone—psoriatic arthritis	8.14e-05	0.00206	CcSEcCtD
Eplerenone—Abdominal pain—Methylprednisolone—psoriatic arthritis	8.12e-05	0.00206	CcSEcCtD
Eplerenone—Infection—Prednisone—psoriatic arthritis	8.08e-05	0.00205	CcSEcCtD
Eplerenone—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	8.06e-05	0.00204	CcSEcCtD
Eplerenone—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	8.06e-05	0.00204	CcSEcCtD
Eplerenone—Back pain—Methotrexate—psoriatic arthritis	8.06e-05	0.00204	CcSEcCtD
Eplerenone—Fatigue—Dexamethasone—psoriatic arthritis	8.05e-05	0.00204	CcSEcCtD
Eplerenone—Fatigue—Betamethasone—psoriatic arthritis	8.05e-05	0.00204	CcSEcCtD
Eplerenone—Shock—Prednisone—psoriatic arthritis	8e-05	0.00203	CcSEcCtD
Eplerenone—Pain—Dexamethasone—psoriatic arthritis	7.99e-05	0.00202	CcSEcCtD
Eplerenone—Pain—Betamethasone—psoriatic arthritis	7.99e-05	0.00202	CcSEcCtD
Eplerenone—Nervous system disorder—Prednisone—psoriatic arthritis	7.98e-05	0.00202	CcSEcCtD
Eplerenone—Skin disorder—Prednisone—psoriatic arthritis	7.9e-05	0.002	CcSEcCtD
Eplerenone—Hyperhidrosis—Prednisone—psoriatic arthritis	7.86e-05	0.00199	CcSEcCtD
Eplerenone—Ill-defined disorder—Methotrexate—psoriatic arthritis	7.73e-05	0.00196	CcSEcCtD
Eplerenone—Anaemia—Methotrexate—psoriatic arthritis	7.7e-05	0.00195	CcSEcCtD
Eplerenone—Feeling abnormal—Dexamethasone—psoriatic arthritis	7.7e-05	0.00195	CcSEcCtD
Eplerenone—Feeling abnormal—Betamethasone—psoriatic arthritis	7.7e-05	0.00195	CcSEcCtD
Eplerenone—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	7.64e-05	0.00194	CcSEcCtD
Eplerenone—Gastrointestinal pain—Betamethasone—psoriatic arthritis	7.64e-05	0.00194	CcSEcCtD
Eplerenone—Malaise—Methotrexate—psoriatic arthritis	7.51e-05	0.0019	CcSEcCtD
Eplerenone—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	7.41e-05	0.00188	CcSEcCtD
Eplerenone—Dizziness—Prednisolone—psoriatic arthritis	7.4e-05	0.00188	CcSEcCtD
Eplerenone—Asthenia—Triamcinolone—psoriatic arthritis	7.38e-05	0.00187	CcSEcCtD
Eplerenone—Abdominal pain—Betamethasone—psoriatic arthritis	7.38e-05	0.00187	CcSEcCtD
Eplerenone—Body temperature increased—Betamethasone—psoriatic arthritis	7.38e-05	0.00187	CcSEcCtD
Eplerenone—Abdominal pain—Dexamethasone—psoriatic arthritis	7.38e-05	0.00187	CcSEcCtD
Eplerenone—Body temperature increased—Dexamethasone—psoriatic arthritis	7.38e-05	0.00187	CcSEcCtD
Eplerenone—Asthenia—Methylprednisolone—psoriatic arthritis	7.37e-05	0.00187	CcSEcCtD
Eplerenone—Insomnia—Prednisone—psoriatic arthritis	7.36e-05	0.00186	CcSEcCtD
Eplerenone—Pruritus—Triamcinolone—psoriatic arthritis	7.28e-05	0.00185	CcSEcCtD
Eplerenone—Cough—Methotrexate—psoriatic arthritis	7.27e-05	0.00184	CcSEcCtD
Eplerenone—Pruritus—Methylprednisolone—psoriatic arthritis	7.27e-05	0.00184	CcSEcCtD
Eplerenone—Dyspepsia—Prednisone—psoriatic arthritis	7.16e-05	0.00182	CcSEcCtD
Eplerenone—Chest pain—Methotrexate—psoriatic arthritis	7.09e-05	0.0018	CcSEcCtD
Eplerenone—Myalgia—Methotrexate—psoriatic arthritis	7.09e-05	0.0018	CcSEcCtD
Eplerenone—Arthralgia—Methotrexate—psoriatic arthritis	7.09e-05	0.0018	CcSEcCtD
Eplerenone—Rash—Prednisolone—psoriatic arthritis	7.06e-05	0.00179	CcSEcCtD
Eplerenone—Dermatitis—Prednisolone—psoriatic arthritis	7.05e-05	0.00179	CcSEcCtD
Eplerenone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	7.04e-05	0.00179	CcSEcCtD
Eplerenone—Diarrhoea—Methylprednisolone—psoriatic arthritis	7.03e-05	0.00178	CcSEcCtD
Eplerenone—Fatigue—Prednisone—psoriatic arthritis	7.01e-05	0.00178	CcSEcCtD
Eplerenone—Headache—Prednisolone—psoriatic arthritis	7.01e-05	0.00178	CcSEcCtD
Eplerenone—Discomfort—Methotrexate—psoriatic arthritis	7.01e-05	0.00178	CcSEcCtD
Eplerenone—Constipation—Prednisone—psoriatic arthritis	6.96e-05	0.00176	CcSEcCtD
Eplerenone—Dizziness—Triamcinolone—psoriatic arthritis	6.81e-05	0.00173	CcSEcCtD
Eplerenone—Dizziness—Methylprednisolone—psoriatic arthritis	6.79e-05	0.00172	CcSEcCtD
Eplerenone—Infection—Methotrexate—psoriatic arthritis	6.75e-05	0.00171	CcSEcCtD
Eplerenone—Feeling abnormal—Prednisone—psoriatic arthritis	6.7e-05	0.0017	CcSEcCtD
Eplerenone—Asthenia—Dexamethasone—psoriatic arthritis	6.7e-05	0.0017	CcSEcCtD
Eplerenone—Asthenia—Betamethasone—psoriatic arthritis	6.7e-05	0.0017	CcSEcCtD
Eplerenone—Nervous system disorder—Methotrexate—psoriatic arthritis	6.67e-05	0.00169	CcSEcCtD
Eplerenone—Gastrointestinal pain—Prednisone—psoriatic arthritis	6.65e-05	0.00169	CcSEcCtD
Eplerenone—Nausea—Prednisolone—psoriatic arthritis	6.65e-05	0.00169	CcSEcCtD
Eplerenone—Pruritus—Betamethasone—psoriatic arthritis	6.61e-05	0.00168	CcSEcCtD
Eplerenone—Pruritus—Dexamethasone—psoriatic arthritis	6.61e-05	0.00168	CcSEcCtD
Eplerenone—Skin disorder—Methotrexate—psoriatic arthritis	6.6e-05	0.00167	CcSEcCtD
Eplerenone—Hyperhidrosis—Methotrexate—psoriatic arthritis	6.57e-05	0.00167	CcSEcCtD
Eplerenone—Vomiting—Triamcinolone—psoriatic arthritis	6.54e-05	0.00166	CcSEcCtD
Eplerenone—Vomiting—Methylprednisolone—psoriatic arthritis	6.53e-05	0.00166	CcSEcCtD
Eplerenone—Rash—Triamcinolone—psoriatic arthritis	6.49e-05	0.00165	CcSEcCtD
Eplerenone—Dermatitis—Triamcinolone—psoriatic arthritis	6.48e-05	0.00164	CcSEcCtD
Eplerenone—Rash—Methylprednisolone—psoriatic arthritis	6.48e-05	0.00164	CcSEcCtD
Eplerenone—Dermatitis—Methylprednisolone—psoriatic arthritis	6.47e-05	0.00164	CcSEcCtD
Eplerenone—Headache—Triamcinolone—psoriatic arthritis	6.45e-05	0.00163	CcSEcCtD
Eplerenone—Headache—Methylprednisolone—psoriatic arthritis	6.43e-05	0.00163	CcSEcCtD
Eplerenone—Abdominal pain—Prednisone—psoriatic arthritis	6.43e-05	0.00163	CcSEcCtD
Eplerenone—Body temperature increased—Prednisone—psoriatic arthritis	6.43e-05	0.00163	CcSEcCtD
Eplerenone—Diarrhoea—Dexamethasone—psoriatic arthritis	6.39e-05	0.00162	CcSEcCtD
Eplerenone—Diarrhoea—Betamethasone—psoriatic arthritis	6.39e-05	0.00162	CcSEcCtD
Eplerenone—Hypotension—Methotrexate—psoriatic arthritis	6.35e-05	0.00161	CcSEcCtD
Eplerenone—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	6.19e-05	0.00157	CcSEcCtD
Eplerenone—Dizziness—Dexamethasone—psoriatic arthritis	6.18e-05	0.00157	CcSEcCtD
Eplerenone—Dizziness—Betamethasone—psoriatic arthritis	6.18e-05	0.00157	CcSEcCtD
Eplerenone—Insomnia—Methotrexate—psoriatic arthritis	6.15e-05	0.00156	CcSEcCtD
Eplerenone—Nausea—Triamcinolone—psoriatic arthritis	6.11e-05	0.00155	CcSEcCtD
Eplerenone—Nausea—Methylprednisolone—psoriatic arthritis	6.1e-05	0.00155	CcSEcCtD
Eplerenone—Dyspnoea—Methotrexate—psoriatic arthritis	6.06e-05	0.00154	CcSEcCtD
Eplerenone—Dyspepsia—Methotrexate—psoriatic arthritis	5.98e-05	0.00152	CcSEcCtD
Eplerenone—Vomiting—Dexamethasone—psoriatic arthritis	5.94e-05	0.00151	CcSEcCtD
Eplerenone—Vomiting—Betamethasone—psoriatic arthritis	5.94e-05	0.00151	CcSEcCtD
Eplerenone—Rash—Betamethasone—psoriatic arthritis	5.89e-05	0.00149	CcSEcCtD
Eplerenone—Rash—Dexamethasone—psoriatic arthritis	5.89e-05	0.00149	CcSEcCtD
Eplerenone—Dermatitis—Dexamethasone—psoriatic arthritis	5.88e-05	0.00149	CcSEcCtD
Eplerenone—Dermatitis—Betamethasone—psoriatic arthritis	5.88e-05	0.00149	CcSEcCtD
Eplerenone—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	5.87e-05	0.00149	CcSEcCtD
Eplerenone—Fatigue—Methotrexate—psoriatic arthritis	5.86e-05	0.00149	CcSEcCtD
Eplerenone—Headache—Dexamethasone—psoriatic arthritis	5.85e-05	0.00148	CcSEcCtD
Eplerenone—Headache—Betamethasone—psoriatic arthritis	5.85e-05	0.00148	CcSEcCtD
Eplerenone—Asthenia—Prednisone—psoriatic arthritis	5.84e-05	0.00148	CcSEcCtD
Eplerenone—Pain—Methotrexate—psoriatic arthritis	5.81e-05	0.00147	CcSEcCtD
Eplerenone—Pruritus—Prednisone—psoriatic arthritis	5.75e-05	0.00146	CcSEcCtD
Eplerenone—Feeling abnormal—Methotrexate—psoriatic arthritis	5.6e-05	0.00142	CcSEcCtD
Eplerenone—Diarrhoea—Prednisone—psoriatic arthritis	5.56e-05	0.00141	CcSEcCtD
Eplerenone—Gastrointestinal pain—Methotrexate—psoriatic arthritis	5.56e-05	0.00141	CcSEcCtD
Eplerenone—Nausea—Dexamethasone—psoriatic arthritis	5.55e-05	0.00141	CcSEcCtD
Eplerenone—Nausea—Betamethasone—psoriatic arthritis	5.55e-05	0.00141	CcSEcCtD
Eplerenone—Dizziness—Prednisone—psoriatic arthritis	5.38e-05	0.00136	CcSEcCtD
Eplerenone—Abdominal pain—Methotrexate—psoriatic arthritis	5.37e-05	0.00136	CcSEcCtD
Eplerenone—Body temperature increased—Methotrexate—psoriatic arthritis	5.37e-05	0.00136	CcSEcCtD
Eplerenone—Vomiting—Prednisone—psoriatic arthritis	5.17e-05	0.00131	CcSEcCtD
Eplerenone—Rash—Prednisone—psoriatic arthritis	5.13e-05	0.0013	CcSEcCtD
Eplerenone—Dermatitis—Prednisone—psoriatic arthritis	5.12e-05	0.0013	CcSEcCtD
Eplerenone—Headache—Prednisone—psoriatic arthritis	5.1e-05	0.00129	CcSEcCtD
Eplerenone—Asthenia—Methotrexate—psoriatic arthritis	4.88e-05	0.00124	CcSEcCtD
Eplerenone—Nausea—Prednisone—psoriatic arthritis	4.83e-05	0.00122	CcSEcCtD
Eplerenone—Pruritus—Methotrexate—psoriatic arthritis	4.81e-05	0.00122	CcSEcCtD
Eplerenone—Diarrhoea—Methotrexate—psoriatic arthritis	4.65e-05	0.00118	CcSEcCtD
Eplerenone—Dizziness—Methotrexate—psoriatic arthritis	4.49e-05	0.00114	CcSEcCtD
Eplerenone—Vomiting—Methotrexate—psoriatic arthritis	4.32e-05	0.0011	CcSEcCtD
Eplerenone—Rash—Methotrexate—psoriatic arthritis	4.29e-05	0.00109	CcSEcCtD
Eplerenone—Dermatitis—Methotrexate—psoriatic arthritis	4.28e-05	0.00109	CcSEcCtD
Eplerenone—Headache—Methotrexate—psoriatic arthritis	4.26e-05	0.00108	CcSEcCtD
Eplerenone—Nausea—Methotrexate—psoriatic arthritis	4.04e-05	0.00102	CcSEcCtD
